Engineered In Vitro Disease Models
The DOI matches its Crossref record; 440 of the 441 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The ultimate goal of most biomedical research is to gain greater insight into mechanisms of human disease or to develop new and improved therapies or diagnostics. Although great advances have been made in terms of developing disease models in animals, such as transgenic mice, many of these models fail to faithfully recapitulate the human condition. In addition, it is difficult to identify critical cellular and molecular contributors to disease or to vary them independently in whole-animal models. This challenge has attracted the interest of engineers, who have begun to collaborate with biologists to leverage recent advances in tissue engineering and microfabrication to develop novel in vitro models of disease. As these models are synthetic systems, specific molecular factors and individual cell types, including parenchymal cells, vascular cells, and immune cells, can be varied independently while simultaneously measuring system-level responses in real time. In this article, we provide some examples of these efforts, including engineered models of diseases of the heart, lung, intestine, liver, kidney, cartilage, skin and vascular, endocrine, musculoskeletal, and nervous systems, as well as models of infectious diseases and cancer. We also describe how engineered in vitro models can be combined with human inducible pluripotent stem cells to enable new insights into a broad variety of disease mechanisms, as well as provide a test bed for screening new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Engineered in vitro disease models have already made incredible progress in academic and pharmaceutical R&D settings, thanks to the high-level engineering approaches which enable one to replicate organ-like complexity and functionality in vitro [202,372–374].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [202]
In the citing paper
“These more relevant physiological structures can promote cell phenotype, metabolic activity, maturation, and functionality, leading to more reliable and more predictive models [202].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [202]
Citations
Cites
1 retracted
Aggarwal, K. P., Narula, S., Kakkar, M., & Tandon, C. (2013) · BioMed Research International · doi:10.1155/2013/292953 · Cited by 354
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“Human iPSCs, which are derived from somatic cells by overexpression of a few transcription factors (3, 4), can be generated from patients with or without a specific disease, and the resulting pluripotent cells can self-renew indefinitely.”
BackgroundInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 1×
“The symptoms result from the death of dopamine-generating cells in a brain region called the substantia nigra, possibly initiated by the abnormal accumulation of α-synuclein protein in the form of Lewy bodies (322, 329).”
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 5×
“Use of this cerebral organoid model revealed that the loss of a protein implicated in microcephaly pathogenesis, called CDK5RAP2, leads to premature neural differentiation at the expense of progenitors (328).”
BackgroundResultInfluentialMetagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657
Self-citationFunctional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“chemical compounds), regulating immune responses, and maintaining gut homeostasis (160), and not surprisingly given these diverse functions, intestinal microbes contribute significantly to human health and disease.”
Background
Research works printed but not linked: 13
- 10.1172/jci24351 · doi:10.1172/jci24351 · Paper page
- Rogers DF, 2007, Respir. Care, 52, 1134
- Shikama Y, 1989, Am. J. Pathol., 134, 1189
- Chantret I, 1988, Cancer Res., 48, 1936
- Ordonez MP, 2012, Semin. Liver Dis., 32, 298
- Sakariassen KS, 1983, J. Lab. Clin. Med., 102, 522
- Toni R, 2007, Acta Biomed., 78, 129
- 10.1290/1071-2690(2000)036 · doi:10.1290/1071-2690(2000)036
- 10.1290/1071-2690(2000)036 · doi:10.1290/1071-2690(2000)036
- Moon DG, 2008, Tissue Eng., 14, 848
- Xie HR, 2010, Chin. Med. J., 123, 1086
- 10.1290/1543-706x(2003)039 · doi:10.1290/1543-706x(2003)039
- Bissell MJ, 1999, Cancer Res., 59, 1757s
Cited by
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Park, S. E., Georgescu, A., & Huh, D. (2019) · Science · doi:10.1126/science.aaw7894 · Cited by 847
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Skardal, A., Murphy, S. V., Devarasetty, M., Mead, I., Kang, H.-W., Seol, Y.-J., Shrike Zhang, Y., Shin, S.-R., Zhao, L., Aleman, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08879-x · Cited by 623
Metadata
- Authors
- Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., Musah, S., Torisawa, Y.-S., van der Meer, A. D., Villenave, R., Yadid, M., Parker, K. K., & Ingber, D. E.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts 02115;
- ORCID
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2015-01-24
- Volume
- 10
- Issue
- 1
- Pages
- 195-262
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2142413049
- Semantic Scholar
- 9ccacf7a73f76aea974853a2f36a16cb183bb068
- Cited by
- 554
- References
- 439
- Citations by year
- 2026: 26 · 2025: 32 · 2024: 34 · 2023: 30 · 2022: 48 · 2021: 58 · 2020: 69 · 2019: 56 · 2018: 69 · 2017: 69 · 2016: 48 · 2015: 15
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Pathology Mechanisms of Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tissue engineering, microfabrication, human pluripotent stem cells, disease modeling, heart disease, lung disease, intestinal diseases, liver disease, kidney disease, cartilage, skin, vascular disease, endocrine disorders, musculoskeletal disorders, neurological disorders, infectious diseases, tumor models, drug screening
- MeSH terms
- Animals, Disease, Humans, Models, Biological, Pathology, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Engineered In Vitro Disease Models. https://app.cochat.ai/papers/10.1146/annurev-pathol-012414-040418
- The paper
- Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., Musah, S., Torisawa, Y.-S., van der Meer, A. D., Villenave, R., Yadid, M., Parker, K. K., & Ingber, D. E. (2015). Engineered In Vitro Disease Models. Annual Review of Pathology: Mechanisms of Disease. https://doi.org/10.1146/annurev-pathol-012414-040418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.